Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Habil Khorakiwala
Person

Habil Khorakiwala

Tracked across 1 events · 9 articles · First seen May 29, 2026 · Last active Jun 01, 2026

Sentiment
0
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 0
Tech
Wockhardt's Zaynich receives US FDA approval
Wockhardt>>>'s novel antibiotic, Zayn Malik>>>, received approval from the United States — Food and Drug Administration>>> for complicated urinary tract infections and pyelonephritis, and from the India — Central Drugs Standard Control Organisation>>> for import…
Impact: Habil Khorakiwala>>>, Chairman of Wockhardt>>>, highlighted the significance of Zayn Malik>>>'s approval in addressing antimicrobial resistance and its status as the first NCE fully developed by an Indian pharmaceutical company to receive FDA approval.
May 29, 2026 · 9 articles
NEWSDESK
Track Habil Khorakiwala live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.